Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: Preliminary results

References

• Stambler N, Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, . The natural history of amyotrophic lateral sclerosis. Neurology. 1993;43:1316–22.
   PubMedGoogle Scholar
• Kurian KM, Forbes RB, Colville S, Swingler RJ. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J Neurol Neurosurg Psychiatry. 2009;80:84–7.
   PubMed Web of Science ®Google Scholar
• Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology. 1998;50:66–72.
   PubMed Web of Science ®Google Scholar
• Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, . Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52:1311–23.
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77:390–2.
   PubMed Web of Science ®Google Scholar
• Carratù P, Spicuzza L, Cassano A, Maniscalco M, Gadaleta F, Lacedonia D, . Early treatment with non-invasive positive pressure ventilation prolongs survival in amyotrophic lateral sclerosis patients with nocturnal respiratory insufficiency. Orphanet J Rare Dis. 2009;10:4–10.
   Google Scholar
• Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124:2000–13.
   PubMed Web of Science ®Google Scholar
• Ward NS, Hill NS. Pulmonary function testing in neuromuscular disease. Clin Chest Med. 2001;22:769–81. Review.
   PubMed Web of Science ®Google Scholar
• Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve. 2006;33:127–32.
   PubMed Web of Science ®Google Scholar
• Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson N, Douglas JA, . Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:194–202.
   PubMed Web of Science ®Google Scholar
• Héritier F, Rahm F, Pasche P, Fitting JW. Sniff nasal inspiratory pressure. A non-invasive assessment of inspiratory muscle strength. Am J Respir Crit Care Med. 1994;150:1678–83.
   PubMed Web of Science ®Google Scholar
• Chaudri MB, Liu C, Watson L, Jefferson D, Kinnear WJ. Sniff nasal inspiratory pressure as a marker of respiratory function in motor neuron disease. Eur Respir J. 2000;15:539–42.
   PubMed Web of Science ®Google Scholar
• Stefanutti D, Benoist MR, Scheinmann P, Chaussain M, Fitting JW. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med. 2000;162:1507–11.
   PubMedGoogle Scholar
• Fitting JW, Paillex R, Hirt L, Aebischer P, Schluep M. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol. 1999;46:887–93.
   PubMed Web of Science ®Google Scholar
• Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171:269–74.
   PubMed Web of Science ®Google Scholar
• Gay PC, Westbrook PR, Daube JR, Litchy WJ, Windebank AJ, Iverson R. Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis. Mayo Clin Proc. 1991;66:686–94.
   PubMed Web of Science ®Google Scholar
• Ferguson KA, Strong MJ, Ahmad D, George CF. Sleep-disordered breathing in amyotrophic lateral sclerosis. Chest. 1996;110:664–9.
   PubMed Web of Science ®Google Scholar
• Kimura K, Tachibana N, Kimura J, Shibasaki H. Sleep-disordered breathing at an early stage of amyotrophic lateral sclerosis. J Neurol Sci. 1999;164:37–43.
   PubMed Web of Science ®Google Scholar
• Newsom-Davis IC, Lyall RA, Leigh PN, Moxham J, Goldstein LH. The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study. J Neurol Neurosurg Psychiatry. 2001;71:482–7.
   PubMed Web of Science ®Google Scholar
• Bradley WG. Overview of motor neuron disease: classification and nomenclature. Clin Neurosci. 1995;3:323–6.
   PubMedGoogle Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society: Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152: 1107–36.
   PubMed Web of Science ®Google Scholar
• Marrone O, Salvaggio A, Insalaco G, Bonsignore MR, Bonsignore G. Evaluation of the POLYMESAM system in the diagnosis of obstructive sleep apnoea syndrome. Monaldi Arch Chest Dis. 2001;56:486–90.
   PubMedGoogle Scholar
• Punjabi NM, Newman AB, Young TB, Resnick HE, Sanders MH. Sleep-disordered breathing and cardiovascular disease: an outcome-based definition of hypopnoeas. Am J Respir Crit Care Med. 2008;177:1150–5.
   PubMed Web of Science ®Google Scholar
• Fallat RJ, Jewitt B, Bass M, Kamm B, Norris FH Jr. Spirometry in amyotrophic lateral sclerosis. Arch Neurol. 1979;36: 74–80.
   PubMed Web of Science ®Google Scholar
• Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, . Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence based review). Muscle Nerve. 1999;22:1104–85.
   PubMed Web of Science ®Google Scholar
• Just N, Bautin N, Danel-Brunaud V, Debroucker V, Matran R, Perez T. The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis. Eur Respir J. 2010;35:353–60.
   PubMed Web of Science ®Google Scholar
• Pinto S, Geraldes R, Vaz N, Pinto A, de Carvalho M. Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study. Clin Neurophysiol. 2009;120: 2082–5.
   PubMed Web of Science ®Google Scholar
• Murphy P, Lyall R, Hart N, Polkey MI. Assessment of respiratory muscle strength in motor neuron disease: is asking enough? Eur Respir J. 2010;35:245–6.
   PubMedGoogle Scholar